2m 2m 2m 2m 2m 2m 2m
BIOMERICA (BMRA)
NASDAQ
$2.25+$0.010 (+0.45%)
Price as of Sep 11, 2026 7:30 PM EDT- $10.3MMarket Cap
- -24.83%1-Year Change
- Medical DevicesIndustry
BIOMERICA (BMRA)
$2.25+$0.010 (+0.45%)
Annual
Quarterly
05/31/2026 | 05/31/2025 | 05/31/2024 | 05/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.5M -16.16% | 5.3M -1.92% | 5.4M +1.42% | 5.3M -71.71% | |
Cost of Revenue | 4.1M -15.00% | 4.8M +0.19% | 4.8M -1.82% | 4.9M -69.21% | |
Gross Profit | 362,000 -27.31% | 498,000 -18.49% | 611,000 +37.00% | 446,000 -85.02% | |
Sales and Marketing Expense | 4.9M +6.11% | 4.6M -15.95% | 5.5M -9.83% | 6.1M +6.77% | |
Research and Development Expense | -788,000 -22.97% | -1.0M -31.39% | -1.5M -5.87% | -1.6M -12.60% | |
Depreciation and Amortization Expense | 77,000 -11.49% | 87,000 +7.41% | 81,000 -3.57% | 84,000 -75.23% | |
Total Operating Expenses | 5.7M +0.83% | 5.6M -19.25% | 7.0M -9.01% | 7.7M +2.10% | |
Operating Profit | -5.3M +3.56% | -5.1M -19.32% | -6.4M -11.85% | -7.2M +59.31% | |
Interest Income | 1.2M +647.27% | 165,000 -61.72% | 431,000 +224.06% | 133,000 +399.27% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 1.2M +647.27% | 165,000 -61.72% | 431,000 +224.06% | 133,000 +399.27% | |
Total Nonoperating Income and Expense | 1.6M +850.30% | 165,000 -61.72% | 431,000 +221.64% | 134,000 +403.02% | |
Income before Taxes | -3.8M -24.54% | -5.0M -16.24% | -5.9M -16.26% | -7.1M +57.28% | |
Income Taxes | 23,000 +2,200.00% | 1,000 -97.62% | 42,000 -17.65% | 51,000 +115.02% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Net Income | -3.8M -24.08% | -5.0M -16.76% | -6.0M -16.27% | -7.1M +57.58% | |
Net Income from Continuing Operations Applicable to Common | -3.8M -24.54% | -5.0M -16.24% | -5.9M -16.26% | -7.1M +57.28% | |
Basic EPS and Net Income | -1.30 -39.81% | -2.16 +500.00% | -0.36 -28.00% | -0.50 +38.89% | |
Diluted EPS and Net Income | -1.30 -39.81% | -2.16 +500.00% | -0.36 -28.00% | -0.50 +38.89% | |
Basic Weighted Average Shares | 2.9M +26.90% | 2.3M -86.34% | 16.8M +18.85% | 14.2M +11.69% | |
Diluted Weighted Average Shares | 2.9M +26.90% | 2.3M -86.34% | 16.8M +18.85% | 14.2M +11.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.3M -45.48% | 2.4M -42.47% | 4.2M -57.09% | 9.7M +64.26% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.3M -45.48% | 2.4M -42.47% | 4.2M -57.09% | 9.7M +64.26% | |
Total Current Assets | 4.0M -17.62% | 4.9M -36.94% | 7.7M -39.59% | 12.8M +35.74% | |
Accumulated Depreciation | 1.5M +2.95% | 1.5M +4.73% | 1.4M +4.73% | 1.3M +1.96% | |
Property and Plant and Equipment and Net | 78,000 -42.22% | 135,000 -32.84% | 201,000 -5.63% | 213,000 -0.69% | |
Total Long-Term Assets | 83,000 -26.55% | 113,000 -44.33% | 203,000 +156.96% | 79,000 -17.35% | |
Total Assets | 6.8M +13.69% | 5.9M -35.76% | 9.3M -35.98% | 14.5M +27.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.5M +42.59% | 1.7M -21.05% | 2.2M +13.32% | 1.9M -3.30% | |
Total Long-Term Debt | 500,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.6M +1,548.00% | 100,000 -78.21% | 459,000 -41.53% | 785,000 -24.39% | |
Total Liabilities | 4.1M +124.40% | 1.8M -30.90% | 2.7M -2.45% | 2.7M -10.48% | |
Retained Earnings | -56.9M +7.10% | -53.2M +10.32% | -48.2M +14.16% | -42.2M +20.35% | |
Total Stockholders Equity | 2.6M -35.93% | 4.1M -37.72% | 6.6M -43.78% | 11.7M +40.83% | |
Total Shares Outstanding | 3.2M +25.49% | 2.5M -84.86% | 16.8M 0.00% | 16.8M +30.73% | |
Cash Flow | |||||
Cash from Operating Activities | -3.4M -10.93% | -3.8M -28.35% | -5.4M -2.06% | -5.5M +1,039.15% | |
Capital Expenditures | N/A N/A | N/A N/A | 51,000 -20.31% | 64,000 +12.48% | |
Cash from Investing Activities | -1,000 -97.30% | -37,000 -67.83% | -115,000 +47.44% | -78,000 -54.21% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.3M +10.56% | 2.1M +2,706.17% | -81,000 -100.86% | 9.4M +292.15% | |
Financials Ratio | |||||
Gross Margin | 8.13% -13.30% | 9.38% -16.90% | 11.28% +35.07% | 8.35% -47.05% | |
Operating Margin | -119.47% +23.52% | -96.72% -17.74% | -117.58% -13.09% | -135.29% +463.10% | |
Return on Assets | -59.48% -9.16% | -65.48% +29.84% | -50.43% -8.79% | -55.29% +41.50% | |
Return on Equity | -112.19% +20.58% | -93.04% +42.53% | -65.28% -8.35% | -71.23% +37.95% | |
Revenue Growth | -16.16% +741.15% | -1.92% -234.92% | 1.42% +101.99% | -71.71% -144.23% | |
Current Ratio | 1.62 -42.22% | 2.80 -20.13% | 3.51 -46.69% | 6.58 +40.37% | |
Cash Ratio | 0.53 -61.76% | 1.38 -27.13% | 1.89 -62.14% | 5.00 +69.85% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow